← Browse by Condition
Medical Condition
metastatic breast cancer
Total Trials
21
Recruiting Now
21
Trial Phases
Phase 1, Phase 2, Phase 1, Phase 3
NCT06064812 Phase 1, Phase 2
Recruiting
A Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC.
Enrollment
99 pts
Location
China
Sponsor
Forward Pharmaceuticals Co., L...
NCT04608357
Recruiting
Integrated Patient Avatars for Guiding Systemic Therapy Treatments in Metastatic Breast Cancer Patients
Enrollment
25 pts
Location
Canada
Sponsor
Sunnybrook Health Sciences Cen...
NCT05900895 Phase 1
Recruiting
Estradiol Plus Olaparib for Breast Cancer (PHOEBE)
Enrollment
6 pts
Location
United States
Sponsor
Mary D Chamberlin
NCT06044623 Phase 3
Recruiting
Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients
Enrollment
495 pts
Location
Finland, Greece, Ita...
Sponsor
Region Örebro County
NCT05349227
Recruiting
Comprehensive Outcomes for After Cancer Health
Enrollment
625 pts
Location
United States
Sponsor
Pack Health
NCT07024173 Phase 3
Recruiting
A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast Cancer
Enrollment
240 pts
Location
China
Sponsor
Shandong Suncadia Medicine Co....
NCT02422641 Phase 2
Recruiting
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
Enrollment
16 pts
Location
United States
Sponsor
Wake Forest University Health ...
NCT05907681
Recruiting
Prospective Observational Study on Outcome of High-precision Hypo-fractionated Radiotherapy in Metastatic Breast Cancer (PRECISE-M)
Enrollment
400 pts
Location
South Korea
Sponsor
Samsung Medical Center
NCT05894239 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
Enrollment
230 pts
Location
United States, Argen...
Sponsor
Hoffmann-La Roche
NCT02102165
Recruiting
AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer.
Enrollment
1,000 pts
Location
Belgium, Germany, Ic...
Sponsor
Breast International Group
NCT07347600
Recruiting
A Study to Evaluate the Effectiveness and Safety of Inavolisib in Participants With Endocrine-resistant, PIK3CA-mutated, Hormone Receptor-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer
Enrollment
500 pts
Location
China
Sponsor
Hoffmann-La Roche
NCT05440929
Recruiting
Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians
Enrollment
15 pts
Location
United States
Sponsor
UNC Lineberger Comprehensive C...
NCT05732051 Phase 2
Recruiting
Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer Patients
Enrollment
60 pts
Location
Norway
Sponsor
University Hospital, Akershus
NCT06827236 Phase 1, Phase 2
Recruiting
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
Enrollment
380 pts
Location
United States, Canad...
Sponsor
BioNTech SE
NCT06388122
Recruiting
DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Metastatic Breast Cancer Patients
Enrollment
100 pts
Location
United States
Sponsor
Mayo Clinic
NCT06991946
Recruiting
Patient-Centric Study to Assess the Impact of Genomic Profiling on the Treatment of Patients With Metastatic Breast Cancer in Spain
Enrollment
300 pts
Location
Spain
Sponsor
SOLTI Breast Cancer Research G...
NCT07002177 Phase 1, Phase 2
Recruiting
A Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BC
Enrollment
196 pts
Location
China
Sponsor
Forward Pharmaceuticals Co., L...
NCT06409390 Phase 2
Recruiting
Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer
Enrollment
15 pts
Location
United States
Sponsor
H. Lee Moffitt Cancer Center a...
NCT06877949
Recruiting
FDG-PET/CT vs. CT for Monitoring Metastatic Breast Cancer
Enrollment
420 pts
Location
Denmark, Germany, It...
Sponsor
Odense University Hospital
NCT03591276 Phase 1, Phase 2
Recruiting
Phase 1b Study of Pegylated Liposomal Doxorubicin and Pembrolizumab in Endocrine-resistant Breast Cancer
Enrollment
15 pts
Location
Israel
Sponsor
Shaare Zedek Medical Center
NCT05720260 Phase 2
Recruiting
Immunotherapy, Hormone Therapy, and AKT Inhibitor for Premenopausal ER Positive MBC
Enrollment
42 pts
Location
Taiwan
Sponsor
National Taiwan University Hos...